NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled
NCT01391143 2022-02-08Safety Study of MGA271 in Refractory CancerMacroGenicsPhase 1 Completed179 enrolled
NCT01017185 2019-05-23Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial LesionsTakara Bio Inc.Phase 1 Completed28 enrolled
NCT00581815 2015-12-28Spectroscopy With Surface Coils and DecouplingMemorial Sloan Kettering Cancer CenterPhase 1 Completed582 enrolled
NCT01872923 2014-06-16Dose Escalating Study for Amphinex-based PCI of Bleomycin.PCI Biotech ASPhase 1 Completed3 enrolled